Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 70,032 | 114,088 | 72,094 | 80,074 | 75,489 |
| General And Administrative Expense | 70,032 | 114,088 | 72,094 | 80,074 | 75,489 |
| Other Operating Expenses | 34,472 | 54,355 | 95,653 | 116,973 | 71,261 |
| Operating Expense | 104,504 | 168,443 | 167,747 | 197,047 | 146,750 |
| Operating Income | -104,504 | -168,443 | -167,747 | -197,047 | -146,750 |
| EBIT | -104,504 | -168,443 | -167,747 | -197,047 | -146,750 |
| Other Income Expense | 61,249 | 20,823 | 5,312 | 130,195 | 3,642 |
| Other Non Operating Income Expenses | -- | -- | 18,425 | 26,813 | 13,557 |
| Special Income Charges | -- | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | 61,249 | 20,823 | -13,113 | 103,382 | -9,915 |
| Pretax Income | -43,255 | -147,620 | -162,435 | -66,852 | -143,108 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -43,253 | -147,620 | -162,435 | -66,852 | -143,108 |
| Net Income From Continuing Operation Net Minority Interest | -43,253 | -147,620 | -162,435 | -66,852 | -143,108 |
| Net Income Including Noncontrolling Interests | -43,255 | -147,620 | -162,435 | -66,852 | -143,108 |
| Net Income Common Stockholders | -43,253 | -147,620 | -162,435 | -66,852 | -143,108 |
| Net Income | -43,253 | -147,620 | -162,435 | -66,852 | -143,108 |
| EBITDA | -104,504 | -168,443 | -167,747 | -197,047 | -146,750 |
| Normalized EBITDA | -165,753 | -189,266 | -154,634 | -300,429 | -136,835 |
| Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Basic Average Shares | 29.3M | 29.3M | 29.3M | 29.3M | -- |
| Diluted Average Shares | 29.3M | 29.3M | 29.3M | 29.3M | -- |
| Total Unusual Items | 61,249 | 20,823 | -13,113 | 103,382 | -9,915 |
| Total Unusual Items Excluding Goodwill | 61,249 | 20,823 | -13,113 | 103,382 | -9,915 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -104,502 | -168,443 | -149,322 | -170,234 | -133,193 |
| Diluted NI Availto Com Stockholders | -43,253 | -147,620 | -162,435 | -66,852 | -143,108 |
| Gain On Sale Of Ppe | -- | -- | -- | -- | 0.00 |
| Net Income Continuous Operations | -43,255 | -147,620 | -162,435 | -66,852 | -143,108 |
| Other Gand A | 68,352 | 112,408 | 70,414 | 76,894 | 71,559 |
| Rent And Landing Fees | 1,680 | 1,680 | 1,680 | 3,180 | 3,930 |
| Rent Expense Supplemental | 1,680 | 1,680 | 1,680 | 3,180 | 3,930 |
| Salaries And Wages | -- | -- | -- | -- | 0.00 |
| Total Expenses | 104,504 | 168,443 | 167,747 | 197,047 | 146,750 |
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 89,122 | 126,223 | 69,036 | 90,370 | 182,928 |
| Cash Cash Equivalents And Short Term Investments | 128,289 | 177,556 | 117,161 | 174,172 | 197,134 |
| Cash Financial | 89,122 | 126,223 | 69,036 | 90,370 | 182,928 |
| Other Short Term Investments | 39,167 | 51,333 | 48,125 | 83,802 | 14,206 |
| Accounts Receivable | 3,813 | 14,021 | 94,304 | 85,696 | 81,742 |
| Receivables | 3,813 | 14,021 | 94,304 | 85,696 | 81,742 |
| Prepaid Assets | 21,167 | 58,283 | 63,209 | 80,108 | 89,879 |
| Current Assets | 153,269 | 249,860 | 274,674 | 339,976 | 368,755 |
| Net PPE | 812,736 | 787,736 | 787,736 | 787,736 | 787,736 |
| Total Non Current Assets | 812,736 | 787,736 | 787,736 | 787,736 | 787,736 |
| Total Assets | 966,005 | 1.0M | 1.1M | 1.1M | 1.2M |
| Payables And Accrued Expenses | 484,536 | 431,543 | 308,737 | 193,181 | 128,295 |
| Other Current Liabilities | -- | -- | -- | 18,425 | 45,238 |
| Current Liabilities | 484,536 | 431,543 | 308,737 | 211,606 | 173,533 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 484,536 | 431,543 | 308,737 | 211,606 | 173,533 |
| Common Stock | 27.4M | 27.4M | 27.4M | 27.4M | 27.3M |
| Capital Stock | 27.4M | 27.4M | 27.4M | 27.4M | 27.3M |
| Additional Paid In Capital | 9.1M | 9.4M | 9.4M | 9.4M | -- |
| Retained Earnings | -36.0M | -36.2M | -36.0M | -35.9M | -35.8M |
| Common Stock Equity | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Stockholders Equity | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Total Equity Gross Minority Interest | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Total Capitalization | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Net Tangible Assets | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Tangible Book Value | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Working Capital | -331,267 | -181,683 | -34,063 | 128,370 | 195,222 |
| Invested Capital | 481,469 | 606,053 | 753,673 | 916,106 | 982,958 |
| Share Issued | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M |
| Ordinary Shares Number | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M |
| Other Equity Interest | -- | -- | -- | -- | 9.5M |
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -31,751 | 39,573 | -43,899 | -126,344 | -93,965 |
| Cash Flow From Continuing Operating Activities | -31,751 | 39,573 | -43,899 | -126,344 | -93,965 |
| Stock Based Compensation | -- | -- | -- | -- | 0.00 |
| Change In Working Capital | 72,751 | 208,015 | 123,847 | 70,703 | 52,785 |
| Changes In Account Receivables | 5,190 | -- | -- | -3,954 | -- |
| Change In Receivables | 5,190 | 80,283 | -8,608 | -3,954 | -7,863 |
| Change In Payables And Accrued Expense | 63,177 | 122,806 | 115,556 | 64,886 | 52,028 |
| Other Non Cash Items | -61,249 | -27,730 | -5,313 | -130,195 | -13,557 |
| Capital Expenditure | -15,000 | -- | -- | -- | -- |
| Purchase Of PPE | -15,000 | -- | -- | 0.00 | -- |
| Net PPE Purchase And Sale | 7,500 | 0.00 | 0.00 | 30,000 | -25,000 |
| Sale Of Investment | 34,848 | 17,614 | 22,583 | 3,768 | -- |
| Net Investment Purchase And Sale | 34,848 | 17,614 | 22,583 | 3,768 | -- |
| Investing Cash Flow | 42,348 | 17,615 | 22,564 | 33,786 | -25,000 |
| Cash Flow From Continuing Investing Activities | 42,348 | 17,614 | 22,583 | 33,768 | -25,000 |
| Issuance Of Capital Stock | -- | 0.00 | -- | -- | 0.00 |
| Net Common Stock Issuance | -- | 0.00 | -- | -- | 0.00 |
| Financing Cash Flow | -- | 0.00 | -- | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | -- | 0.00 | -- | -- | 0.00 |
| Changes In Cash | 10,597 | 57,187 | -21,334 | -92,558 | -118,965 |
| Beginning Cash Position | 78,525 | 69,036 | 90,370 | 182,928 | 301,893 |
| End Cash Position | 89,122 | 126,223 | 69,036 | 90,370 | 182,928 |
| Free Cash Flow | -46,751 | 39,573 | -43,899 | -126,344 | -118,965 |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Prepaid Assets | 4,384 | 4,926 | 16,899 | 9,771 | 8,620 |
| Common Stock Issuance | -- | 0.00 | -- | -- | 0.00 |
| Gain Loss On Sale Of PPE | -- | -- | -- | -- | 0.00 |
| Net Income From Continuing Operations | -43,253 | -147,620 | -162,433 | -66,852 | -143,108 |
| Net Other Financing Charges | -- | -- | -- | -- | 0.00 |
| Net Other Investing Changes | -- | -- | -19.00 | 18.00 | -- |
| Operating Gains Losses | -- | -- | -- | -- | 0.00 |
| Proceeds From Stock Option Exercised | -- | -- | -- | -- | 0.00 |
| Sale Of PPE | 22,500 | 0.00 | 0.00 | 30,000 | 0.00 |
| Unrealized Gain Loss On Investment Securities | -- | -- | -- | 14,618 | 9,915 |